As Novartis expands its manufacturing capabilities, our new Carlsbad facility will help deliver time-sensitive cancer treatments to patients, meeting future demand.

Novartis is fighting COVID-19 broadly, from committing R&D resources to better understand and treat the disease to reaching out to individuals and communities in need.

These scientifically advanced technologies may help transform millions of patients’ lives

Novartis begins U.S. pilot program for OdySight, a clinically tested mobile application designed to help monitor vision remotely.

Novartis is sharing information and resources to empower people affected by prostate cancer during Prostate Cancer Awareness Month